Inhibrx Biosciences Inc's market cap is currently $185.29M. The company's EPS TTM is $; its P/E ratio is ―; Inhibrx Biosciences Inc is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.80M	$ 2.18M	$ 7.13M	$ 12.81M	$ 9.09M
Gross Profit	$ 609.00K	$ -668.00K	$ 4.44M	$ -60.69M	$ -38.81M
Operating Income	$ -219.22M	$ -129.12M	$ -76.56M	$ -67.44M	$ -43.71M
EBITDA	$ -206.69M	$ -125.82M	$ -76.56M	$ -67.44M	$ -42.60M
Net Income	$ -241.36M	$ -145.23M	$ -81.77M	$ -75.64M	$ -51.40M
Balance Sheet
Cash & Short-Term Investments	$ 277.92M	$ 273.87M	$ 131.30M	$ 128.66M	$ 11.54M
Total Assets	$ 307.89M	$ 290.88M	$ 150.45M	$ 143.74M	$ 26.49M
Total Debt	$ 210.14M	$ 202.07M	$ 70.47M	$ 37.45M	$ 41.73M
Net Debt	$ -67.78M	$ -71.80M	$ -60.83M	$ -91.21M	$ 30.19M
Total Liabilities	$ 264.39M	$ 232.82M	$ 98.07M	$ 68.27M	$ 120.06M
Stockholders' Equity	$ 43.50M	$ 58.06M	$ 52.38M	$ 75.47M	$ -93.57M
Cash Flow
Free Cash Flow	$ -197.90M	$ -115.99M	$ -81.19M	$ -49.33M	$ -33.89M
Operating Cash Flow	$ -193.31M	$ -115.30M	$ -80.32M	$ -47.97M	$ -32.08M
Investing Cash Flow	$ -4.59M	$ -686.00K	$ -809.00K	$ -1.36M	$ -1.81M
Financing Cash Flow	$ 201.96M	$ 258.55M	$ 83.77M	$ 166.46M	$ 43.33M

Currency in USD

Inhibrx Biosciences Inc Earnings and Revenue History

Income Statement >

Inhibrx Biosciences Inc Debt to Assets

Balance Sheet >

Inhibrx Biosciences Inc Cash Flow

Cash Flow >

Inhibrx Biosciences Inc Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing